Screener
DaVita DVA U.S.Dialysis — Foreign currency and other adjustments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by DaVita in its filing.
Tagged under the XBRL concept us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments.
The source filing: DaVita’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 5:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000927066-26-000062
| Line item | U.S. dialysis | Other — Ancillary services | Consolidated |
|---|---|---|---|
| Balance at December 31, 2024 | $6,517,220 | $857,996 | $7,375,216 |
| Acquisitions | 10,396 | 61,288 | 71,684 |
| Foreign currency and other adjustments | — | 98,195 | 98,195 |
| Balance at December 31, 2025 | 6,527,616 | 1,017,479 | 7,545,095 |
| Acquisitions | 21,098 | 9,542 | 30,640 |
| Foreign currency and other adjustments | — | 6,578 | 6,578 |
| Balance at March 31, 2026 | $6,548,714 | $1,033,599 | $7,582,313 |
| Balance at March 31, 2026: |
Item 1. Condensed Consolidated Financial Statements:
FAQ
- What is DaVita's u.s.dialysis — foreign currency and other adjustments?
- DaVita (DVA) reported u.s.dialysis — foreign currency and other adjustments of $0 in Q1 2026.
- What does u.s.dialysis — foreign currency and other adjustments mean?
- Reflects non-operational adjustments to the carrying value of assets or liabilities within the U.S. dialysis segment, including impacts from foreign currency translation or accounting reclassifications. While the segment is U.S.-focused, these adjustments account for peripheral financial impacts that do not stem from core clinical operations. It helps isolate the underlying performance of the domestic business from accounting noise.
Ask your AI about DaVita's u.s.dialysis — foreign currency and other adjustments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude